Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows from Operating Activities:
Net income	$ 14,558	$ 14,104
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,852	2,949
Deferred income tax	3,701	575
Provision for bad debts	(652)	122
Stock issued for costs and expenses	1,955
(Increase) decrease in operating assets, net:
Accounts, medical receivable and management fee(s)	(5,025)	(3,005)
Notes receivable	(13)
Costs and estimated earnings in excess of Billings on uncompleted contracts	(248)	649
Inventories	(378)	(13)
Prepaid expenses and other current assets	(214)	(132)
Other assets		(883)
Increase (decrease) in operating liabilities, net:
Accounts payable	331	(164)
Other current liabilities	(3,593)	(1,681)
Customer advances	(24)	79
Other liabilities	18	1
Due to related medical practices	(135)
Net cash provided by operating activities	13,132	12,601
Cash Flows from Investing Activities:
Purchases of property and equipment	(3,069)	(2,594)
Cost of patents	(88)	(75)
Net cash used in investing activities	(3,157)	(2,669)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(23)	(150)
Additional acquisition costs		(58)
Distributions to noncontrolling interests	(4,815)	(4,455)
Repayment of notes receivable from employee stockholders	9	5
Net cash used in financing activities	(4,829)	(4,658)
Net Increase in Cash and Cash Equivalents	5,146	5,274
Cash and Cash Equivalents - Beginning of Period	19,634	10,140
Cash and Cash Equivalents - End of Period	$ 24,780	$ 15,414